Application
IHC-P analysis of human kidney tissue using FLJ22167 antibody at 4.0-8.0μg/ml.Application
WB analysis of HepG2 cells using FLJ22167 antibody at 1.25μg/ml. Lane A : marker Lane B : HepG2 cells| Product Name | FLJ22167 antibody, N-term |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to FLJ22167This gene encodes a transmembrane protein, which is a component of the B9 complex involved in the formation of the diffusion barrier between the cilia and plasma membrane. Mutations in this gene cause Joubert syndrome (JBTS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013] |
| Immunogen | A synthetic peptide corresponding to a N-terminal region of Human FLJ22167 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC-PWB |
| *Optimal dilutions/concentrations should be determined by the researcher.
: |
|
| Species Reactivity | Human |
| Predicted Reactivity | Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 93%; Human: 100%; Mouse: 93%; Rabbit: 100%; Rat: 100%; Zebrafish: 79% |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Synonyms | ALYE870 PRO1886 TMEM231 JBTS20 |
|---|---|
| Target | FLJ22167 |
| Molecular Weight(MW) | 36 KDa (note) |
Application
IHC-P analysis of human kidney tissue using FLJ22167 antibody at 4.0-8.0μg/ml.
Application
WB analysis of HepG2 cells using FLJ22167 antibody at 1.25μg/ml. Lane A : marker Lane B : HepG2 cells| Positive Control | HepG2 |
|---|---|
| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher.
: |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. For short-term storage, store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
